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Abstract—Hypercapnia is frequently used to accelerate
emergence from anesthesia in the OR, but not in the post
anesthesia care unit (PACU). To this end, a reemergence
device has been proposed that will take advantage of hy-
percapnia to reduce recovery time and number of adverse
clinical events experienced in the PACU. In order to design
a device capable of meeting the wide range of breathing
patterns exhibited by patients under sub-anesthetic levels
of anesthesia, a simulation package was developed to
model gas exchange during rebreathing. Using this model
the user is able to manipulate variables such as tidal
volume, breathing rate, metabolic rate, reservoir volume,
supplemental O2 rate, etc. and view the resulting gas
fractions of O2, CO2, and N2 in the lungs over time.
INTRODUCTION
THE cardiovascular and respiratory system work intandem to provide the necessary gas exchange for
cellular metabolic activity throughout the body. The
respiratory system exchanges O2 and CO2 between the
atmosphere and blood; the circulatory system delivers the
O2 to cells throughout the body and transports CO2—
a byproduct of cellular respiration—from the cells back
to the lungs. When CO2 levels fluctuate, such as when
metabolic activity changes, the cardiovascular and respi-
ration systems are modified accordingly to compensate.
For example, if the arterial partial pressure of CO2
(PaCO2) rises, respiration will increase and vasodilation
will occur, increasing blood flow and gas exchange in
order to flush the body of excess CO2. When PaCO2 is
reduced, the opposite occurs. In an anesthesia setting,
this relationship is frequently taken advantage of.
Induced hypercapnia, or elevated PaCO2 , is often used
to accelerate a patient’s recovery from anesthesia[1], [2].
Anesthetic vapors can be removed in the same way
that excess CO2 is flushed from the body. Recently,
the FDA approved a device, called the QED-100, that
accomplishes this task during the emergence phase of
anesthesia in the OR[3]. This device incorporates a
rebreathing reservoir to induce hypercapnia and a char-
coal filter to soak up expelled anesthetic gases. Studies
have shown that the QED-100 is capable of reducing
emergence times by approximately 55%[3], [4], [5].
However, as mentioned, this device is only used in the
OR until the patient is conscious and able to maintain a
patent airway, after which they are moved to PACU to
continue recovery until discharge criteria are met.
The incidence of adverse clinical events is much
higher in the PACU than the OR. As a patient becomes
more alert in the PACU, a greater awareness of pain is
evident, so additional analgesics are often administered,
which can react synergistically with trace amounts of
anesthetic and cause loss of consciousness, difficulties
breathing, etc. Studies have shown that of 42,000 patients
monitored, 23–24% experienced complications in the
PACU, while only 3.8–5.1% encountered difficulties in
the operating room[6], [7], [8]. The need for a faster and
safer recovery from anesthesia in the PACU is apparent.
To this end, a device has been proposed for use in the
PACU that will take advantage of hypercapnia in order to
reduce recovery time and the number of adverse clinical
events. The goal is to integrate the functionality of the
QED-100 with a standard oxygen mask; however, the
design criteria for such a device is quite demanding. In
contrast to the OR where ventilation is performed and
monitored closely by an anesthesia machine, a patient in
the PACU can on their own—albeit an irregular, shallow,
and slow breathing pattern due to sub-anesthetic levels
of drug still present in their body. In this state they are at
greater risk of hypoxia, and often supplemental oxygen
is given to compensate. The use of a hypercapnia-
inducing device, like the QED-100, in this setting would
further increase the risk of hypoxia. Therefore, as part
of the recovery device being designed for the PACU,
a port for supplemental oxygen will be included. This
presents another problem: addition of oxygen may dilute
the rebreathed air sufficiently as to diminish and even
obliterate the hypercapnic effect of rebreathing. Hence,
the design of the recovery device must be robust in its
ability to induce hypercapnia while avoiding hypoxia for
a wide range of breathing patterns.
To understand and optimize the relationship between
rebreathing and oxygen supplementation, it was sug-
gested that a model be created to simulate rebreathing
with oxygen supplementation. The model had to be
capable of simulating various breathing patterns while
tracking gas concentrations over time. As a first step in
designing a recovery device for the PACU, this paper
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Fig. 1. Model of a patient with rebreathing device as simulated. The
tube represents the rebreathing reservoir, and the volume elements
are indicated as segments of the tube. Adapted from Silverthorn, pg
562[9]. Arrows and labels added separately.
describes the model being designed to simulate the
proposed device.
METHODS
The simulation package was programed using Matlab
(Mathworks, Natick, MA). The model was broken into
two systems: a breathing model—to drive the system,
and a rebreathing reservoir, which causes the change in
gas concentrations over time.
The breathing simulation was defined by the relation-
ship between lung compliance, airway resistance, and
relative pressures between the atmosphere and lungs.
The first order relationship between these parameters was
estimated using Eurler’s method as follows,




V (i+ 1) = V (i) +4t ·Q(i) (2)
Q(i) = P (i)/R (3)
where P is pressure, Q is flow, C is compliance, V
is volume, R is resistance, 4t is the time increment,
and i is a particular step in time. The user was able to
modified each of these parameters so that various types
of breathing patterns could be simulated.
During inspiration, the flow of air was considered to
be constant, comparable to the function of a ventilation
machine. Expiration began when a defined tidal volume
was reached. The flow of air during expiration was
characterized by the compliance and resistance of the
lungs as defined in equations 1, 2, and 3.
In order to simulate the gas exchange within the
rebreathing reservoir, the space was divided into small
volume elements (Figure 1). The math then became
a simple accounting problem where gas exchange be-
tween each volume element was calculated and tracked
through each step in time. The user was able to modify
parameters relating to the rebreathing reservoir, which
included reservoir volume, number of volume elements,
location of supplement oxygen port, and the flow rate of
supplemental oxygen.
Figure 1 shows a representation of a patient with the
rebreathing device as simulated. Beyond the parameters
already mentioned, the user could also define the number
of breaths to simulate, the functional residual volume
of the lungs, tidal volume, the rate of metabolic con-
sumption of O2 and production of CO2, the relative gas
fractions of the atmosphere, and the initial gas fractions
in the lungs and rebreathing reservoir. Thus nearly any
combination of patient breathing pattern and rebreathing
reservoir could be simulated.
RESULTS
A screenshot of the simulation model is shown in
Figure 2. This particular simulation was carried out for
100 breaths at 10 breaths per minute, which equalled
approximately 10 min as shown in the bottom graph.
The top three graphs show the pressure, volume, and
flow curves for one minute of the simulation, which
allows the user to observe the details of each breath.
The three panels on the left are where the user changes
the various parameters of the system before running the
next simulation.
From the pressure graph on top it can be seen how the
pressure rises linearly during inspiration and then decays
exponentially during expiration. This was expected since,
as was mentioned, flow during inspiration was consid-
ered to be constant, as evidenced by the plateau in the
flow curve. The curve during expiration follows the first
order relationship between pressure, lung compliance,
airway resistance, and flow (Equations 1, 2, and 3). The
curves appear similar to the curves seen on a typical
ventilator.
The bottom graph shows the gas fractions in the lung
with respect to time. Notice how the CO2 and O2 curves
rise while flushing out the N2. This is similar to the
desired result of the device. Oxygen needs to remain
high to prevent hypoxia, but not so high as to dilute
CO2 and loose hypercapnic effects. It should be noted
that the axis on the right corresponds to the CO2 gas
fraction; those on left correspond to O2 and N2. The
zigzag nature of the curves represents the inspiration and
expiration cycles. This particular simulation places the
supplemental oxygen port in or near the face mask and
supplies 5 L/min of O2.
DISCUSSION
It should first be mentioned that work is currently
being done to verify this simulation using a bench test
model so that, presently, the validity of this model is
unknown—except for the qualitative observations al-
ready made. That being said, several speculations can
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Fig. 2. Screenshot of simulation. One minute of the pressure, volume, and flow graphs are displayed on top. The resulting gas fractions in
the lungs for a 10 min simulation are shown in the bottom graph. Notice that the axis on the right is for the CO2curve. The panels on the
left are for changing the various parameter of the simulation.
still be made regarding the limitations of the present
model.
The curves presented in Figure 2 appear to be similar
to those expected using a ventilation machine; however,
in the PACU a patient is breathing spontaneously. The
inspiration curve would appear less linear and more first
order, like the expiration curve. It needs to be determined
whether the error that is introduced by assuming a
constant flow during inspiration is significant enough to
invalidate the model.
It is known that PaCO2affects respiration[10]. This
model does not take into account the fact that respiration
rate and depth may change as hypercapnia sets in. Also,
this model assumes a regular, consistent breathing rate
throughout the duration of the simulation. In reality, a pa-
tient’s breathing patterns can vary from breath to breath.
Most likely the simulation will need to be modified in
order to test variability in the breathing pattern.
The simulation also assumes no leakage between the
oxygen mask and the face of the patient. Leakage can
greatly influence the effect of rebreathing. This too
could easily be incorporated into the simulation. Both
simulation and bench tests will need to be done to
quantify the effect of leakage so that the device can be
designed to account for a certain degree of leakage.
Another assumption of the model is perfect mixing of
the gases: during each step in time it is assumed that
when a small volume of gas moves from one volume
segment to the next the gases mix perfectly so that
the exiting gas takes on the new gas fraction. This
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assumption may be negligible, especially if the volume
element is sufficiently small, but worthy of note if the
volume element is increased.
Ideally the best simulation would be one that could
include variables that were defined as close to reality as
possible, but unfortunately this is not always possible.
Certain assumptions have to be made in order to make
the computations manageable. Sometimes those assump-
tions can introduce significant errors into the model,
which can then hopefully be tested and verified in a
real experiment. Such is the case with this model. As
mentioned, bench tests, using a mechanical lung, are
currently being conducted to validate the model.
CONCLUSIONS
The work done thus far in creating a model to simulate
rebreathing with oxygen supplementation has been suc-
cessful in meeting the initial goals of the design process
and serves as a base for future work. Several assumptions
need to be tested, such as constant inspiratory flow,
the continuous, non-varying breathing pattern, and the
effects of hypercapnia on respiration. Aside from those
obvious limitations, the model also needs to be validated
with bench tests, which have begun.
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